ESPE Abstracts (2016) 86 P-P2-292

Use of Continuous Glucose Monitoring Helps Selecting Insulin Therapy in Thalassemic Adolescents with Glycemic abnormalities

Ashraf Solimana, Fawzia Alyafiea, Mohamed Yassinb & Nagwa Aldarsya


aHamad Medical Center, Doha, Qatar; bAlamal Hospital HMC, Doha, Qatar


Background: Continuous Glucose Monitoring (CGMS) is a useful method to detect the variability of glucose fluctuations and offers the opportunity for better assessment of glucose homeostasis in TM patients and response to therapy.

Objective and hypotheses: Does real-life monitoring of blood glucose add to the therapeutic approach to patients with TM who have glycemic abnormalities?

Method: In two thalassemic adolescents with glycemic abnormalities we tested the benefit of monitoring blood glucose to support the therapeutic decision.

Results: A 15 year old male with TM presented with nocturia. His FBG was 5.6 mmol/l and OGTT showed a BG level at 2 h of 8.5 mmol/l. His CGMS showed a diabetic range of BG after dinner and overnight. Based on this tracing, a basal insulin (Glargine) was prescribed at night. A satisfactory response was recorded by CGMS. In addition, a 14 year old girl with TM with no symptoms related to glycemic abnormalities. Her FBG was 4.9 mmol/l and an OGTT showed a BG level at 2 h of 6.9 mmol/l (IGT). CGMS tracing showed prolonged persistent hyperglycemia after lunch suggesting a need for prandial insulin to cover her carbohydrate load. Insulin aspart before lunch properly controlled her glycemia.

Conclusion: Our results demonstrate that the CGMS is a useful method to detect the variability of glucose fluctuations and offers the opportunity for better assessment and control of glucose homeostasis in TM patients.

Article tools

My recent searches

No recent searches.